Kloetzel et al., Journal of medicinal and pharmaceutical chemistry, 1959, vol. 1, p. 197,205
作者:Kloetzel et al.
DOI:——
日期:——
IL-8 RECEPTOR ANTAGONISTS
申请人:SmithKline Beecham Corporation
公开号:EP1185261A1
公开(公告)日:2002-03-13
EP1185261A4
申请人:——
公开号:EP1185261A4
公开(公告)日:2004-02-25
[EN] IL-8 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DES RECEPTEURS DE L'IL-8
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2000076495A1
公开(公告)日:2000-12-21
This invention provides for a method of treating a chemokine mediated disease, wherein the chemokine is one which binds to an IL-8 α or β receptor and which method comprises administering an effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. In particular the chemokine is IL-8.
74. Anhydro-compounds from nitrogen-containing derivatives of thioglycollic acid. Part II. Glyoxaline and benziminazole compounds